Winner Medical Co Ltd (300888) — Capital Reinvestment Ratio

Latest as of September 2025: 0.58x

Winner Medical Co Ltd (300888) has a Capital Reinvestment Ratio of 0.58x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥384.40 Million) in capital expenditures (CN¥221.37 Million). See Winner Medical Co Ltd (300888) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.58x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥384.40 Million
CNY

Capital Expenditures

CN¥221.37 Million
CNY

Data as of

Sep 2025
Most recent filing

Winner Medical Co Ltd Capital Reinvestment Ratio (2013–2025)

This chart tracks Winner Medical Co Ltd's Capital Reinvestment Ratio across 13 annual periods.

Annual Capital Reinvestment Ratio for Winner Medical Co Ltd (2013–2025)

Year-by-year Capital Reinvestment Ratio for Winner Medical Co Ltd from 2013 to 2025. For live market cap and broader valuation context, see Winner Medical Co Ltd (300888) market capitalisation.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2025 0.39x CN¥1.67 Billion CN¥647.91 Million ▼ -45.3%
2024 0.71x CN¥1.27 Billion CN¥900.89 Million ▲ +0.5%
2023 0.71x CN¥1.06 Billion CN¥753.07 Million ▲ +76.2%
2022 0.40x CN¥2.98 Billion CN¥1.20 Billion ▼ -52.9%
2021 0.85x CN¥871.69 Million CN¥743.27 Million ▲ +609.1%
2020 0.12x CN¥4.77 Billion CN¥573.26 Million ▼ -83.9%
2019 0.75x CN¥599.77 Million CN¥446.90 Million ▼ -45.4%
2018 1.36x CN¥467.86 Million CN¥638.14 Million ▼ -7.9%
2017 1.48x CN¥357.80 Million CN¥530.04 Million ▲ +131.6%
2016 0.64x CN¥450.14 Million CN¥287.97 Million ▼ -35.6%
2015 0.99x CN¥269.29 Million CN¥267.31 Million ▲ +46.5%
2014 0.68x CN¥203.96 Million CN¥138.17 Million ▼ -30.2%
2013 0.97x CN¥124.39 Million CN¥120.69 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow